SIC 2836 – Biological Products, Except Diagnostic Substances (Biotech)
| Valuation | |
|---|---|
| Market Cap ($M) | 465.51 |
| Enterprise Value ($M) | 423.64 |
| Book Value ($M) | 368.42 |
| Book Value / Share | 3.24 |
| Price / Book | 1.26 |
| NCAV ($M) | 193.74 |
| NCAV / Share | 1.70 |
| Price / NCAV | 2.40 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | -0.34 |
| Return on Assets (ROA) | -0.26 |
| Return on Equity (ROE) | -0.34 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 8.48 |
| Current Ratio | 8.48 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 331.54 |
| Assets | 506.22 |
| Liabilities | 137.80 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 63.53 |
| Operating Income | -177.61 |
| Net Income | -160.93 |
| Earnings Per Share Basic And Diluted | n/a |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | -132.26 |
| Cash from Investing | 112.67 |
| Cash from Financing | 0.09 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13D/A | Redmile Group, LLC | 14.90 | 17.07 | |
| 13G/A | Vanguard Group Inc | 9.43 | -6.47 | |
| 13G | Boxer Capital, LLC | 6.30 | ||
| 13G/A | Capital World Investors | 0.00 | -100.00 | |
| 13G | Point72 Asset Management, L.P. | 5.00 | ||
| 13G/A | BlackRock Inc. | 11.40 | 15.29 | |
| 13G/A | State Street Corp | 1.89 | -18.05 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| File Date | Form | SEC Filings |
|---|---|---|
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
(click for more detail) |
||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 244,058 | 2,072,277 | 11.78 | |
| 490,497 | 3,716,201 | 13.20 | |
| 331,032 | 1,128,315 | 29.34 | |
| 440,478 | 1,263,409 | 34.86 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| ESPR – Esperion Therapeutics, Inc. | ETNB – 89bio, Inc. |
| ETON – Eton Pharmaceuticals, Inc. | FBLG – FibroBiologics, Inc. |
| FHTX – Foghorn Therapeutics Inc. |